Month: May 2021

SER-109, an oral microbiome therapeutic, safely protects against Clostridioides difficile recurrence for up to 24 weeks, according to a recent phase 3 trial. Three days of treatment with purified Firmicutes spores reduced risk of recurrence by 54%, suggesting a sustained, clinically meaningful response, according to a multicenter study presented at this year’s Digestive Disease Week® (DDW). “Antibiotics targeted
0 Comments
President Joe Biden requested notable increases for certain federal medical programs in his first fully detailed budget request, while also highlighting efforts to address gun violence and the opioid epidemic and prepare better for pandemics. Biden’s fiscal 2022 request, released Friday afternoon, serves as a formal marker for the White House’s views on national health
0 Comments
ROCKVILLE, Md.–(BUSINESS WIRE)–May 26, 2021– GlycoMimetics, Inc. (Nasdaq: GLYC) announced today that clinicians at Washington University School of Medicine in St. Louis have dosed the first patient in an investigator-sponsored trial (IST) evaluating uproleselan as a prophylactic agent to reduce gastrointestinal (GI) toxicities associated with high-dose melphalan in autologous hematopoietic cell transplantation (auto-HCT) for multiple myeloma (MM). Dr. Keith Stockerl-Goldstein, M.D., Professor
0 Comments
FDA Approves Camcevi (leuprolide mesylate) for the Treatment of Advanced Prostate Cancer TAIPEI, May 26, 2021 /PRNewswire/ — Foresee Pharmaceuticals (6576.TWO), (“Foresee”) announced today that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Camcevi 42 mg, a ready-to-use 6-month subcutaneous depot formulation of leuprolide mesylate, as a treatment
0 Comments
May 26, 2021 Audience: Consumer May 26, 2021 — Today, the U.S. Food and Drug Administration and the Federal Trade Commission issued warning letters to five companies for illegally selling dietary supplements that claim to cure, treat, mitigate, or prevent infertility and other reproductive health disorders in violation of the Federal Food, Drug, and Cosmetic
0 Comments
A young man receives his Covid-19 vaccination at a vaccination clinic. People receive the Moderna vaccine in Milford, Pennsylvania. Preston Ehrler | LightRocket | Getty Images Roughly half of all Americans have received at least one dose of a Covid vaccine, based on Centers for Disease Control and Prevention data published Thursday, as nationwide infection
0 Comments
Teplizumab got a reticent thumbs-up from FDA advisors for an indication in delaying progression of at-risk patients to clinical type 1 diabetes (T1D). The agency’s Endocrinologic and Metabolic Drugs Advisory Committee on Thursday voted 10-7 that sufficient evidence of benefit outweighed the risks for this novel biologic. However, a number on both sides indicated how
0 Comments
May is Mental Health Awareness Month. Over the next few weeks, OncoLink will feature blogs about common mental health challenges faced by cancer patients, caregivers, and healthcare professionals. Please remember, if you are in crisis, help is available. National Suicide Prevention Lifeline 800-273-8255 National Alliance on Mental Health (NAMI) Helpline 800-950-6264 A caregiver is someone
0 Comments
Viruses like COVID-19, SARS, bovine spongiform, swine flu and avian flu all have something in common: They all come from animals, described by scientists as zoonotic diseases. Yet, these diseases do not really “come from animals.” After all, it is not like animals conspire against humans, throwing COVID-19 over the backyard fence. When we say
0 Comments
Cancer treatments carry with them plenty of side effects, including gastrointestinal issues. Diarrhea and constipation are especially common. These can make treatment all the more unpleasant and even cause lingering issues. However, a new study may have found a way to protect gut health from chemotherapy. Researchers at Northwestern University tested how certain types of
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. “If there’s one universal truth amongst all the patients I’ve interviewed, it’s that they’re often brushed aside, pigeonholed, or, frankly, abandoned,” says Greg Vanichkachorn, MD, MPH, a family physician and founder of Mayo Clinic’s COVID-19 Activity Rehabilitation Program (CARP). Take a
0 Comments
In April we marked World Health Day, a World Health Organization (WHO) celebration that began in 1950. This year’s theme calls for building a fairer, healthier world for everyone.  It shines a tragic spotlight on the struggle for equity and the health inequities minorities face, especially with COVID-19. The lessons of COVID According to the
0 Comments
A new study suggests that private investor ownership of dermatology practices has little impact on spending, but does result in a small increase in the number of patients seen per dermatologist, and slightly higher reimbursement per clinician. The authors reported that — with an average of five quarters postacquisition — there was no statistically significant differential
0 Comments
Achilles Therapeutics has been listed and is open to public investment on the world’s second largest stock exchange Cancer Research UK’s spinout, Achilles Therapeutics plc (‘Achilles’), has raised $175.5 million to invest in the development of new cancer immunotherapies through the closing of its initial public offering (IPO). This milestone marks the ‘birth’ of a
0 Comments
FDA Approves Myfembree as the First Once-Daily Treatment for Heavy Menstrual Bleeding Associated With Uterine Fibroids BASEL, Switzerland and NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved Myfembree (relugolix 40 mg, estradiol 1 mg,
0 Comments
News FDA Alerts FDA Restricts Use of Ocaliva (obeticholic acid) in Primary Biliary Cholangitis Patients with Advanced Cirrhosis Due to Risk of Serious Liver Injury May 26, 2021 Audience:  Patient, Health Professional, Pharmacy  ISSUE: The FDA is restricting the use of the liver disease medicine Ocaliva (obeticholic acid) in patients having primary biliary cholangitis (PBC) with
0 Comments
Tackle the anxiety that comes with this fear of open spaces and being trapped in situations that are difficult to escape It’s a panic disorder that centres on an intense fear about the possibility of experiencing anxiety or panic attacks in a situation where it’s difficult to escape, or of being in open spaces –
0 Comments